Bridging the Diversity Gap in Clinical Trials

People from racial and cultural minorities are not effectively targeted by trial recruiters for clinical studies. This gap can lead to sub-optimal development of new medicines and can further disparities in health outcomes among racial and cultural groups.

To understand the importance of bridging the diversity gap, we sat down with Melva Covington, Director, Global Evidence and Value Development at Sanofi. She shared her experience with clinical trials that include patients from diverse, under-represented backgrounds in pharmaceutical research.

Please subscribe to view the analysis report